Jubilant Life Sciences zooms 10.2% during the week. It retakes 50-DMA as well as 200-DMA the stock got momentum after its Singapore based wholly-owned subsidiary company, Drug Discovery and Development Solutions, acquired stake in Inipharm Inc., US.
Jubilant Life Sciences zooms 10.2% during the week. It retakes 50-DMA as well as 200-DMA the stock got momentum after its Singapore based wholly-owned subsidiary company, Drug Discovery and Development Solutions, acquired stake in Inipharm Inc., US.